These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 27137985
1. Arginase-1 is frequently positive in hepatoid adenocarcinomas. Chandan VS, Shah SS, Torbenson MS, Wu TT. Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985 [Abstract] [Full Text] [Related]
2. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Terracciano LM, Glatz K, Mhawech P, Vasei M, Lehmann FS, Vecchione R, Tornillo L. Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391 [Abstract] [Full Text] [Related]
3. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma. Giedl J, Büttner-Herold M, Wach S, Wullich B, Hartmann A, Agaimy A. Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483 [Abstract] [Full Text] [Related]
4. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, Rivera MN, Ting DT, Deshpande V. Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287 [Abstract] [Full Text] [Related]
5. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature. Haninger DM, Kloecker GH, Bousamra Ii M, Nowacki MR, Slone SP. Mod Pathol; 2014 Apr; 27(4):535-42. PubMed ID: 24030743 [Abstract] [Full Text] [Related]
6. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA. Supriatna Y, Kishimoto T, Uno T, Nagai Y, Ishikura H. Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893 [Abstract] [Full Text] [Related]
7. Albumin gene expression in adenocarcinomas with hepatoid differentiation. Foschini MP, Baccarini P, Dal Monte PR, Sinard J, Eusebi V, Rosai J. Virchows Arch; 1998 Dec; 433(6):537-41. PubMed ID: 9870687 [Abstract] [Full Text] [Related]
8. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. Radwan NA, Ahmed NS. Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165 [Abstract] [Full Text] [Related]
13. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. Mod Pathol; 2013 Jun 30; 26(6):782-91. PubMed ID: 23348905 [Abstract] [Full Text] [Related]
14. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Timek DT, Shi J, Liu H, Lin F. Am J Clin Pathol; 2012 Aug 30; 138(2):203-10. PubMed ID: 22904131 [Abstract] [Full Text] [Related]
15. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative. Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V. Hum Pathol; 2017 Nov 30; 69():90-95. PubMed ID: 28970136 [Abstract] [Full Text] [Related]
17. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Yan BC, Gong C, Song J, Krausz T, Tretiakova M, Hyjek E, Al-Ahmadie H, Alves V, Xiao SY, Anders RA, Hart JA. Am J Surg Pathol; 2010 Aug 30; 34(8):1147-54. PubMed ID: 20661013 [Abstract] [Full Text] [Related]